- Inflammatory Bowel Disease: Updates on Molecular Targets for Biologics
-
Katsanos K, Papadakis
- KMID: 2412224
- Gut Liver.
- 2017 Jul;11(4):455-463.
- doi: 10.5009/gnl16308
Therapy for inflammatory bowel disease (IBD) has changed, with several new agents being evaluated. The era of anti-tumor necrosis factor (anti-TNF) antibody therapy saw remarkable progress in IBD therapy. Some... -
- CITED
-
- Close
- SHARE
-
- Close
- Proinflammatory cytokines in irritable bowel syndrome: a comparison with inflammatory bowel disease
-
Mitselou A, Grammeniatis V, Varouktsi , Papadatos , Katsanos K, Galani V
- KMID: 2501373
- Intest Res.
- 2020 Jan;18(1):115-120.
- doi: 10.5217/ir.2019.00125
Background/Aims: Irritable bowel syndrome (IBS) is a common disease often considered as a functional intestinal disorder. Inflammation in IBS is a quite intriguing theory. The aim of this study was... -
- CITED
-
- Close
- SHARE
-
- Close
